medroxyprogesterone acetate has been researched along with Liver Neoplasms in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (7.14) | 18.7374 |
1990's | 16 (57.14) | 18.2507 |
2000's | 8 (28.57) | 29.6817 |
2010's | 2 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CW; Wang, SN; Wei, RJ; Yeh, YT | 1 |
Aogi, K; Hara, F; Kiyoto, S; Ohsumi, S; Takabatake, D; Takahashi, M; Takashima, S | 1 |
Jassem, J; SosiĆska-Mielcarek, K; Zaucha, R | 1 |
Hirakawa, K; Ishikawa, T; Kato, Y; Nakata, B; Ogawa, Y; Onoda, N; Takagaki, K; Takashima, T | 1 |
Chai, CY; Lee, KT; Wang, SN; Yang, SF; Yeh, YT | 1 |
Abeshima, S; Hasegawa, N; Ichimura, T; Kaneko, H; Kawabata, M; Konishi, K; Nakayama, T | 1 |
Furukawa, J; Kinuta, M; Maruyama, H; Okamura, J; Ooi, H; Sekimoto, M; Tateishi, H; Yayoi, E | 1 |
Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T | 1 |
Asaumi, S; Iino, Y; Ishikawa, H; Iwanami, K; Kawashima, K; Kobayashi, J; Kubota, K; Matsumoto, H; Morishita, Y; Yokoe, T | 1 |
Atkins, JN; Bearden, JD; Case, LD; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; O'Rourke, MA; Pavy, MD; Powell, BL | 1 |
Gondo, H; Nakajima, Y; Sato, N; Sato, Y; Uchino, J; Une, Y | 1 |
Fujii, T; Kanno, K; Ogata, T; Roppongi, T; Yokota, T | 1 |
Hoshino, K; Ikeda, H; Koyama, T; Morishita, Y; Nakamura, M | 1 |
Fujitake, S; Kataoka, S; Maeda, Y; Nozaki, H; Shimizu, M; Tohyama, M | 1 |
Hino, N; Isozaki, H; Matsukawa, H; Naomoto, Y; Sadamori, H; Saito, S; Shirakawa, Y; Takakura, N; Tanaka, N; Yamatsuji, T | 1 |
Ino, H; Kanaya, Y; Kawasaki, K; Maruyama, S; Okumoto, T; Otani, J; Soda, M; Yokoyama, N | 1 |
Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Nakayama, S; Oota, D; Shimizu, H | 1 |
Akaike, H; Ashizawa, I; Chiba, S; Imamura, K; Mitui, T; Miyauchi, Y; Muto, S; Nakagomi, H; Nakazawa, M; Okuda, J; Takahashi, M | 1 |
Hara, Y; Hikosaka, Y; Iwase, H; Kobayashi, S; Toyama, T; Yamashita, H | 1 |
Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I | 1 |
Fujiwara, Y; Furukawa, J; Hasuike, Y; Maruyama, H; Miyoshi, H; Naoi, M; Nishihara, M; Okahara, K; Takata, N; Yayoi, E | 1 |
Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K | 1 |
Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y | 1 |
Kamiyama, T; Kawamukai, Y; Nagabuchi, E; Nakajima, Y; Ogasawara, K; Sato, N; Sato, Y; Uchino, J; Une, Y | 1 |
Aoki, T; Ishikawa, M; Kakuta, T; Kimura, K; Kusama, M; Suzuki, K; Yoshimatsu, A | 1 |
Camaggi, CM; Pannuti, F; Strocchi, E | 1 |
1 review(s) available for medroxyprogesterone acetate and Liver Neoplasms
Article | Year |
---|---|
Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.
Topics: Androgens; Antineoplastic Agents, Hormonal; Carcinoma, Hepatocellular; Estrogens; Female; Humans; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Megestrol Acetate; Sex Characteristics | 2013 |
5 trial(s) available for medroxyprogesterone acetate and Liver Neoplasms
Article | Year |
---|---|
[A comparison of intra-arterial chemoembolization and infusion chemotherapy for liver metastases of breast cancer].
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoembolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Infant, Newborn; Infusion Pumps, Implantable; Iodized Oil; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Prognosis | 1995 |
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Soft Tissue Neoplasms | 1995 |
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Regression Analysis; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen | 1994 |
Chemohormonal therapy of unresectable hepatocellular carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Diseases; Leukopenia; Liver Diseases; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen | 1993 |
Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Topics: Adolescent; Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis B; Humans; Kenya; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Thailand; Time Factors | 1991 |
22 other study(ies) available for medroxyprogesterone acetate and Liver Neoplasms
Article | Year |
---|---|
Examination of the use of Exemestane in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Retrospective Studies; Tamoxifen | 2011 |
Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Prognosis; Treatment Outcome | 2004 |
[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Taxoids; Tegafur; Uracil | 2005 |
Potential role of leptin expression in hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Leptin; Liver Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Prognosis; Survival Analysis; Treatment Outcome | 2006 |
[A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Treatment Outcome | 2007 |
Hormonal contraception. ACOG Technical bulletin. Number 198-October 1994 (replaces No. 106, July 1987) American College of Obstetricians and Gynecologists.
Topics: Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Liver Neoplasms; Medroxyprogesterone Acetate; Risk Factors; Uterine Cervical Neoplasms | 1995 |
[A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Ovariectomy | 1994 |
[A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged | 1998 |
[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cholestasis; Cyclophosphamide; Doxorubicin; Drainage; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tamoxifen; Tegafur; Toremifene; Uracil | 1999 |
[A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Tamoxifen | 1999 |
Multiple liver metastases of breast cancer: report of a case successfully treated with hormone-cytokine-chemotherapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Interferon-alpha; Liver Neoplasms; Medroxyprogesterone Acetate; Tumor Necrosis Factor-alpha | 1999 |
[A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction | 2000 |
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Tamoxifen; Tegafur; Uracil | 2000 |
[A patient with recurrent breast cancer whose liver metastasis regressed following combined use of weekly docetaxel and MPA.5'-DFUR].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Paclitaxel; Taxoids | 2001 |
Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms | 1992 |
[Combination of transarterial chemoembolization and endocrine therapy for liver metastases of breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Doxorubicin; Drug Therapy, Combination; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged | 1991 |
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction | 1991 |
[Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Ifosfamide; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Sodium; Sodium Bicarbonate | 1990 |
[A case of double cancer of gastric and hepatocellular carcinoma associated with cirrhosis treated by hepatic resection after intra-hepatic arterial infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Doxorubicin; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Cirrhosis; Liver Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Multiple Primary; Stomach Neoplasms; Tamoxifen | 1990 |
[Complete remission, obtained by multidisciplinary treatment of recurrent breast cancer with carcinomatous pleuritis, and cervical lymph node and diver metastasis].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Pleurisy; Remission Induction | 1989 |
The role of pharmacokinetics in the clinical treatment of metastases.
Topics: Antineoplastic Agents; Doxorubicin; Epirubicin; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms; Tamoxifen | 1988 |